Lewis & Clark Ventures, a Midwest-based venture capital firm, announced a $25 million multi-year commitment from Express Scripts to help source and support early stage healthcare innovation. The capital will supplement the company’s ongoing efforts to innovate smarter pharmacy solutions that deliver better outcomes for patients.
Lewis & Clark Ventures plans to fund between $3 to $7 million into companies that demonstrate disruptive innovation and are generating revenue. Lewis & Clark Ventures is particularly interested in companies focused in healthcare IT and solutions that have the ability to increase prescription drug adherence, support personalized and accountable care, offer connectivity for patients and improve public health.
“Innovation drives our industry-leading suite of cost-saving, clinically-based solutions that deliver quality, cost-effective pharmacy care to tens of millions of people,” said Dr. Glen Stettin, Senior Vice President and Chief Innovation Officer, Express Scripts in a statement. “We continually scout for technology, ideas and people that are changing healthcare, and we believe that our investment with Lewis & Clark Ventures will further accelerate innovation across the Midwest, especially here in St. Louis.”
